Xbrane Biopharma AB (STU:7XB0) Float Percentage Of Total Shares Outstanding: 0.00% (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:7XB0 Xbrane Biopharma AB STU:7XB0
51 GF Score
Price €0.75
GF Value €0.51
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Xbrane Biopharma AB Float Percentage Of Total Shares Outstanding?

Xbrane Biopharma AB STU:7XB0 -2.85% 51 Float Percentage Of Total Shares Outstanding is 0.00% as of Aug. 27, 2026. GuruFocus rates STU:7XB0 with a GF Score™ of 51/100 and a GF Value™ of €0.51 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Xbrane Biopharma AB's float shares is 0.00 Mil. Xbrane Biopharma AB's total shares outstanding is 20.61 Mil. Xbrane Biopharma AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Xbrane Biopharma AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Xbrane Biopharma AB's Institutional Ownership is 1.95%.

STU:7XB0
51GF Score
Xbrane Biopharma AB STU:7XB0
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xbrane Biopharma AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Xbrane Biopharma AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/20.61
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Xbrane Biopharma AB (STU:7XB0) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Aug. 27, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Xbrane Biopharma AB and its competitors.
Is Xbrane Biopharma AB's Float Percentage Of Total Shares Outstanding too high?
Xbrane Biopharma AB's current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Xbrane Biopharma AB has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Xbrane Biopharma AB's Float Percentage Of Total Shares Outstanding compare to VRTX and REGN?
Xbrane Biopharma AB's Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Xbrane Biopharma AB and its competitors. Xbrane Biopharma AB's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xbrane Biopharma AB stock overvalued right now?
Based on GuruFocus' analysis, Xbrane Biopharma AB (STU:7XB0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.51, compared to a current price of €0.75 — trading 47.1% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Xbrane Biopharma AB's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Xbrane Biopharma AB (STU:7XB0), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xbrane Biopharma AB (STU:7XB0) Overvalued in 2026?

Based on GuruFocus' analysis, Xbrane Biopharma AB stock appears to be overvalued. The current stock price of €0.75 is trading 47.1% above its estimated GF Value™ of €0.51. GuruFocus considers Xbrane Biopharma AB to be Significantly Overvalued.

Key valuation signals for STU:7XB0:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: €0.51 vs. price of €0.75 (47.1% above fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the STU:7XB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Xbrane Biopharma AB Business Description

Other Exchanges XBRANE:Sweden7XB0:Germany
Address Scheeles vag 5, Solna, SWE, 171 65
Xbrane Biopharma AB is a biotechnology company that develops biosimilars. The company follows drugs on already approved biological drugs that can be introduced at a lower price after the patent expires on the original drug. The company has a patented protein production platform with greater productivity than standard systems for producing proteins in E.coli host cells. The company's product candidate is Ximluci, a ranibizumab biosimilar (original drug Lucentis) used in the treatment of various eye diseases, mainly the wet form of age-related macular degeneration. Other products in preclinical stage of the company includes Xdivane and Xdarzane.
51GF Score

Get the complete analysis for STU:7XB0

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.75
Price
€0.51
GF Value